Inhibition of monocyte/macrophage migration to a spinal cord injury site by an antibody to the integrin αD: A potential new anti-inflammatory treatment

Experimental Neurology

Volumn 166, Issue 1, 2000, Pages 52-64

  Mabon, P Joy ^a   Weaver, Lynne C ^a   Dekaban, Gregory A ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

Adhesion molecule; Extravasation; Inflammation; Integrin; Leukocytes; Macrophages; Monoclonal antibody; Neutrophils; Spinal cord injury; D 2

Indexed keywords

ANTIINFLAMMATORY AGENT; BETA2 INTEGRIN ANTIBODY; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; DRUG MECHANISM; LEUKOCYTE MIGRATION INHIBITION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD INJURY; TISSUE CULTURE;

EID: 0033756931     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2000.7488     Document Type: Article

References (53)

1. Therapy study on the experimental injury of spinal cord. IV. High doses of methyl-prednisolone
2. Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1
3. A new mechanism of methylprednisolone and other corticosteroids action demonstrated in vitro: Inhibition of a proteinase (calpain) prevents myelin and cytoskeleton protein degradation
4. Vascular cell adhesion molecule-1 modulation by turnout necrosis factor in experimental allergic encephalomyelitis
5. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection
6. Suppression of phagocytosis by dexamethasone in macrophage culture: Inability of arachidonic acid, indomethacin and nordihydroguaiaretic acid to reverse the inhibitory response mediated by a steroid-inducible factor
7. Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats
8. Endothelial-leukocyte adhesion molecules
9. Identification of an inducible endothelial-leukocyte adhesion molecule
10. Delayed demyelination and macrophage invasion: A candidate for 'secondary' cell damage in spinal cord injury
11. Macrophages and inflammatory damage in spinal cord injury
12. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury: Results of the Second National Acute Spinal Cord Injury Study
13. Administration of methylprednisolone for 24 or 48 h or tirilazad mesylate for 48 h in the treatment of acute spinal cord injury: Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial - National Acute Spinal Cord Injury Study
14. Anti-adhesion molecule therapy in experimental autoimmune encephalomyelitis
15. Acute inflammatory response in spinal cord following impact injury
16. Intercellular adhesion molecule-2, a second counter-receptor for CD11a/ CD18 (leukocyte function-associated antigen-1), provides a co-stimulatory signal for T-cell receptor-initiated activation of human T cells
17. + lymphocyte subpopulation in peripheral blood
18. Effects of intravenous methylprednisolone therapy on leukocyte and soluble adhesion molecule expression in MS
19. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site
20. Changes in PMN leukocyte migration activity and complement C3d levels in RA patients with high disease activity during steroid treatment
21. Integrin regulation of leukocyte inflammatory functions
22. Comparison of the performance of anti-CD7 and anti-CD38 bispecific antibodies and immunotoxins for the delivery of saporin to a human T- cell acute lymphoblastic leukemia cell line
23. Consequences of high-dose steroid therapy for acute spinal cord injury
24. Inhibition of mononuclear phagocytes reduces ischemic injury in the spinal cord
25. Expression of a novel β2 integrin (αdβ2) on human leukocytes and mast cells
26. αdβ2 integrin is expressed on human eosinophils and functions as an alternative ligand for vascular cell adhesion molecule 1 (VCAM-1)
27. Lymphocyte adhesion and transendothelial migration in the central nervous system: The role of LFA-1, ICAM-1, VLA-4 and VCAM-1
28. Involvement of an intercellular adhesion molecule 1-dependent pathway in the pathogenesis of secondary changes after spinal cord injury in rats
29. Promotion of neutrophil chemotaxis through differential regulation of beta 1 and beta 2 integrins
30. Neuronal cell death in the ischemic spinal cord: The effect of methylprednisolone
31. Mouse CD23 regulates monocyte activation through an interaction with the adhesion molecule CD11b/CD 18
32. Correlation between myeloperoxidase-quantified neutrophil accumulation and ischemic brain injury in the rat: Effects of neutrophil depletion
33. Effect of methylprednisolone in compression trauma to the feline spinal cord
34. Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats
35. An inducible endothelial cell surface glycoprotein mediates melanoma adhesion
36. Effect of duration of acute spinal cord compression in a new acute cord injury model in the rat
37. Cytokine-induced expression of vascular cell adhesion molecule-1 (VCAM-1) by astrocytes and astrocytoma cell lines
38. An antibody to lymphotoxin and tumour necrosis factor prevents transfer of experimental allergic encephalomyelitis
39. An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils
40. Requirements for αd in IgG immune complex-induced rat lung injury
41. Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro
42. Therapy with antibody against leukocyte integrin VLA-4 (CD49d) is effective and safe in virus-facilitated experimental allergic encephalomyelitis
43. Adhesion receptors of the immune system
44. Spinal cord injury in the rat
45. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms
46. The leukocyte integrin αDβ2 binds VCAM-1: Evidence for a binding interface between I domain and VCAM-1
47. A novel leukointegrin, αdβ2, binds preferentially to ICAM-3
48. Lymphocyte adhesion mediated by integrins
49. Beta 2-integrin-mediated signal up-regulates counterreceptor ICAM-1 expression on human monocytic cell line THP-1 through tyrosine phosphorylation
50. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin
51. Hu23F2G, an antibody recognizing the leukocyte CD11/CD18 integrin, reduces injury in a rabbit model of transient focal cerebral ischemia
52. Experimental analysis of progressive necrosis after spinal cord trauma in the rat: Etiological role of the inflammatory response